Literature DB >> 8545272

Ethnicity and psychopharmacology. Bridging the gap.

K M Lin1, D Anderson, R E Poland.   

Abstract

Taken together, the literature reviewed clearly indicates that the disposition and effect of a large number of psychotropic agents are influenced substantially by ethnicity and culture. Recent advances in the realm of pharmacokinetics, pharmacogenetics, and pharmacodynamics have led to a greater understanding of some of the mechanisms responsible for such differences. In comparison, much less currently is known regarding how various psychosocial factors impinge on drug responses in different cultural settings. Progress in research in this area is important for clinical reasons, as psychiatric clinicians will increasingly be confronted with patients with divergent ethnic and cultural backgrounds. In addition, knowledge derived from such research will contribute significantly to a better understanding of how the effects of psychotropic agents are mediated, and also should be valuable for the drug development industry that will have to take into account the increasingly diversifying domestic and international markets.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8545272

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  4 in total

Review 1.  What will be the role of pharmacogenetics in evaluating drug safety and minimising adverse effects?

Authors:  V Ozdemir; N H Shear; W Kalow
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Overcoming challenges in the diagnosis and treatment of attention-deficit/hyperactivity disorder in African Americans.

Authors:  Rahn K Bailey; Dion L Owens
Journal:  J Natl Med Assoc       Date:  2005-10       Impact factor: 1.798

Review 3.  Attention-deficit/hyperactivity disorder in African American youth.

Authors:  Rahn K Bailey; Shahid Ali; Shagufta Jabeen; Hilary Akpudo; Jaymie U Avenido; Theresa Bailey; Jessica Lyons; Amelia A Whitehead
Journal:  Curr Psychiatry Rep       Date:  2010-10       Impact factor: 5.285

4.  Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate.

Authors:  Francois-Pierre Joubert; Bonginkosi Chiliza; Robin Emsley; Laila Asmal
Journal:  S Afr J Psychiatr       Date:  2021-01-11       Impact factor: 1.550

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.